4//SEC Filing
BOBULSKY SUSAN 4
Accession 0001062993-24-017564
CIK 0001478320other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 5:47 PM ET
Size
6.7 KB
Accession
0001062993-24-017564
Insider Transaction Report
Form 4
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-10-08−5,000→ 0 totalExercise: $1.98Exp: 2024-10-13→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2024-10-08$1.98/sh+5,000$9,900→ 253,290 total
Footnotes (1)
- [F1]The options are fully exercisable.
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001820885
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 5:47 PM ET
- Size
- 6.7 KB